Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $25.8600 (3.11%) ($24.4100 - $25.9000) on Mon. May. 6, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.71% (three month average) | RSI | 48 | Latest Price | $25.8600(3.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.3% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -1.855% in a week (0% probabilities). VXX(-12%) VIXM(-8%) TLT(-4%) IFRA(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.855% (StdDev 3.71%) | Hourly BBV | 0 () | Intraday Trend | 5.2% | | | |
|
1 - 5 Day Possible Target | $16.5(-36.19%) | Resistance Level | $26.13 | 5 Day Moving Average | $24.58(5.21%) | 10 Day Moving Average | $25.79(0.27%) | 20 Day Moving Average | $26.13(-1.03%) | To recent high | -6.8% | To recent low | 33.1% | Market Cap | $1.606b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |